跳至主要内容
临床试验/CTIS2022-502727-21-00
CTIS2022-502727-21-00招募中1 期

A prospective, post-authorisation long-term follow up trial of patients previously treated with imlifidase prior to kidney transplantation, including a non-comparative concurrent reference cohort - 20-HMedIdeS-20

Hansa Biopharma AB0 个研究点目标入组 144 人开始时间: 2023年2月9日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Signed Informed Consent obtained before any trial-related procedures., Willingness and ability to comply with the protocol., Previously transplanted in the clinical trial 20-HmedIdeS-19 (PAES).

排除标准

  • Inability by the judgment of the investigator to participate in the trial for other reasons.

研究者

相似试验

已完成
不适用
Prospective Observational Post-Authorisation Study on Fresh-transfer and Freeze-all treatments of ART patients undergoing controlled ovarian stimulation with Follitropin alfa (Bemfola®)
DRKS00022943GEDEON RICHTER PHARMA GmbH956
进行中(未招募)
不适用
ong-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive DisorderMajor Depressive Disorder
EUCTR2012-004169-42-PLH. Lundbeck A/S1,184
进行中(未招募)
不适用
ong-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive DisorderMajor Depressive Disorder
EUCTR2012-004169-42-SKH. Lundbeck A/S1,184
进行中(未招募)
不适用
ong-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive DisorderMedDRA version: 16.0Level: LLTClassification code 10025461Term: Major depressive disorder, recurrent episode, severe degree, without mention of psychotic behaviorSystem Organ Class: 100000004873MedDRA version: 14.1Level: LLTClassification code 10025463Term: Major depressive disorder, single episodeSystem Organ Class: 100000004873MedDRA version: 16.0Level: LLTClassification code 10025469Term: Major depressive disorder, single episode, severe degree, without mention of psychotic behaviorSystem Organ Class: 100000004873MedDRA version: 16.0Level: LLTClassification code 10025462Term: Major depressive disorder, recurrent episode, unspecified degreeSystem Organ Class: 100000004873MedDRA version: 16.0Level: LLTClassification code 10025467Term: Major depressive disorder, single episode, moderate degreeSystem Organ Class: 100000004873MedDRA version: 16.0Level: LLTClassification code 10025457Term: Major depressive disorder, recurrent episode, mild degreeSystem Organ Class: 100000004873MedDRA version: 16.0Level: LLTClassification code 10025458Term: Major depressive disorder, recurrent episode, moderate degreeSystem Organ Class: 100000004873MedDRA version: 16.0Level: LLTClassification code 10025470Term: Major depressive disorder, single episode, unspecified degreeSystem Organ Class: 100000004873Major Depressive Disorder
EUCTR2012-004169-42-FIH. Lundbeck A/S1,184
进行中(未招募)
1 期
ong-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive DisorderMajor Depressive Disorder
EUCTR2012-004169-42-GBH. Lundbeck A/S26
A long-term follow-up trial of patients previously... | 临床试验